Global Cancer Biomarkers Market 2015-2019

  • Published: Jan 2015
  • Pages: 89
  • SKU: IRTNTR5058
Technavio

The 2021-2025 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

About Cancer Biomarkers

Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process. Cancer Biomarkers are proteins or metabolites indicative of tumor state and progression characteristics. They are non-invasive, enable high speed cancer diagnosis and also enhance early cancer detection and screening.  The best example of a cancer biomarker is that of prostate specific antigen. PSA is measured in the blood to screen for and monitor treatment for prostate cancer. PSA, as a biomarker helps the doctors to monitor the progress of the cancer. It also helps to evaluate the response of the cancer to the treatment therapy.

TechNavio's analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.26 percent over the period 2014-2019.

Covered in this Report

TechNavio's report, Global Cancer Biomarkers Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cancer Biomarkers market worth, market forecasting, market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

 

Key Regions

•Americas

• APAC

• EMEA  

   

Key Vendors

• Abbott Laboratories

• Affymetrix

• Illumina

• Qiagen

• Quest Diagnostics

• Roche Diagnostics

 

Other Prominent Vendors

• Agendia

• Agilent Technologies

• Alere

• Ambry Genetics

• Amgen

• Astellas Pharma US

• Astex Pharmaceuticals

• Atossa Genetics

• Beckman Coulter

• Becton, Dickinson and Company

• Biocurex

• bioMérieux

• Celldex Therapeutics

• Clarient

• diaDexus

• DiagnoCure

• Epigenomics

• EUSA Pharma

• Exact Sciences

• Foundation Medicine

• Fujirebio Diagnostics

• Genomic Health

• Geron

• Immunomedics

• Morphotek

• Myriad Genetics

• Nodality

• Northwest Biotherapeutics

• Ocimum Biosolutions

• Oncothyreon

• OriGene

• Polymedco

• Radient Pharmaceuticals

• Randox Laboratories

• Siemens Healthcare

• US Biomarkers

• Vermillion

 

Market Driver

• Increased Prevalence of Cancer

• For a full, detailed list, view our report

 

Market Challenge

• Regulatory and Reimbursement Issues

• For a full, detailed list, view our report

 

Market Trend

• Growing Popularity of Companion Diagnostics

• For a full, detailed list, view our report

 

Key Questions Answered in this Report

• What will the market size be in 2019 of the global cncer biomarkers market and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Read More Read Less

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Incidence and Prevalence
08. Biomarkers Used in Cancer Diagnosis
08.1.1 Cancer Biomarkers : FDA Approved till 2012
08.1.2 Cancer Biomarkers : FDA Approved 2013
09. FDA Approval Process for Protein-Based Cancer Biomarkers
10. Geographical Segmentation
10.1 Cancer Biomarkers Market in the Americas
10.1.1 Market Size and Forecast
10.1.2 Cancer Biomarkers Market in US
10.2 Cancer Biomarkers Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Cancer Biomarkers Market in APAC Region
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Analysis 2014
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Affymetrix
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation
19.2.4 Business Segmentation by Revenue 2013
19.2.5 Business Segmentation by Revenue 2012 and 2013
19.2.6 Sales by Geography
19.2.7 Business Strategy
19.2.8 Key Information
19.2.9 SWOT Analysis
19.3 Illumina
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation
19.3.4 Geographical Segmentation by Revenue 2013
19.3.5 Business Strategy
19.3.6 Key Information
19.3.7 SWOT Analysis
19.4 Qiagen
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Product Segmentation by Revenue 2013
19.4.4 Product Segmentation by Revenue 2012 and 2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Recent Developments
19.4.8 SWOT Analysis
19.5 Quest Diagnostics
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2011-2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 Roche Diagnostics
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Business Segmentation by Revenue 2013
19.6.4 Geographical Segmentation by Revenue 2013
19.6.5 Business Strategy
19.6.6 Key Developments
19.6.7 SWOT Analysis
20. Other Reports in this Series

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>